Acute Severe and Chronic Eating Disorders in Children: Etiology, Clinical Features, Diagnosis, and Management
An Academic Review Article for Pediatrics (Child Diseases)
Authors:
Harun Al Farhad Dhali, Ishrat Perween, Anchal Tiwari
Subject: Pediatrics (Child Diseases)
Faculty: International Medical Faculty
University: Osh State University
Year: 2026
Corresponding Author: farhadharunal@gmail.com
Abstract
Background. Eating disorders in children encompass an extraordinarily broad clinical spectrum. At one extreme lie conditions driven by poverty, food insecurity, and infectious disease—most notably severe acute malnutrition (SAM), which continues to affect approximately 19 million children under five years of age globally and remains responsible for hundreds of thousands of preventable deaths each year. At the other extreme are psychiatric disorders such as anorexia nervosa and bulimia nervosa, which have shown steadily rising prevalence and dramatically increased hospitalization rates over the past two decades. Both categories converge during critical windows of childhood development, placing affected children at substantial risk for impaired physical growth, disrupted neurodevelopment, and lasting psychosocial harm.
Objective. This review aims to offer a clinically integrated and practically oriented overview of the major acute and chronic forms of eating disorders in children. It draws together perspectives from nutritional science and child psychiatry, covering etiology, pathophysiology, clinical presentations, diagnostic frameworks, and evidence-based management approaches informed by World Health Organization (WHO) protocols, DSM-5 diagnostic criteria, and current peer-reviewed literature.
Methods. A narrative review methodology was employed, drawing on peer-reviewed publications retrieved from PubMed, Scopus, and Web of Science, alongside WHO technical guidelines, NICE recommendations, and the DSM-5 and ICD-11 classification frameworks. Preference was given to systematic reviews, meta-analyses, and authoritative clinical guidelines published within the past ten years.
Conclusion. Whether rooted in nutritional deprivation or psychiatric pathology, pediatric eating disorders require prompt recognition, coordinated multidisciplinary care, and family-centered therapeutic approaches. Integrated management strategies that address both the nutritional and psychological dimensions of these conditions produce meaningfully better outcomes. This review highlights the urgent need for enhanced clinician education, structural integration of health services, and sustained community-level intervention.
Keywords: pediatric eating disorders, severe acute malnutrition, anorexia nervosa, ARFID, kwashiorkor, marasmus, failure to thrive, family-based treatment
1. Introduction
Eating disorders in children present clinicians with one of the most diagnostically and therapeutically demanding areas of pediatric medicine. The conditions involved are extraordinarily varied in their origins and mechanisms. On one end of the spectrum lies severe acute malnutrition, driven by household poverty, armed conflict, and food insecurity; on the other are chronic psychiatric disorders in which fundamentally distorted relationships with food and body image drive potentially fatal patterns of restriction or purging. While these categories may appear superficially distinct, they frequently intersect in clinical practice, and a child presenting with unexplained weight loss or growth failure may have a nutritional etiology, a psychiatric one, or both simultaneously.
The global burden of these conditions is substantial by any measure. Wasting—the clinical term for acute malnutrition—affects tens of millions of young children worldwide, with case fatality rates in untreated populations approaching 30%. Concurrently, anorexia nervosa carries the highest standardized mortality ratio of any recognized psychiatric illness, with deaths attributable to cardiac arrhythmias, metabolic derangements, and suicide. The COVID-19 pandemic has added a further layer of urgency: school closures, social isolation, heightened screen exposure, and disruption of routine all created conditions that accelerated the onset and clinical deterioration of psychiatric eating disorders in young people at an alarming pace.
Despite the magnitude of this burden, eating disorders in children remain significantly underdiagnosed. Primary care physicians may dismiss early behavioral signs as developmental phases, while the atypical presentations common in younger children—food refusal framed as gastrointestinal discomfort, somatic complaints at mealtimes, or anxiety-driven avoidance without explicit articulation of weight concerns—do not map cleanly onto diagnostic criteria originally developed for adult populations. This review directly addresses that gap by synthesizing current evidence across the full spectrum of pediatric eating disorders, with the goal of improving clinician recognition, facilitating earlier intervention, and supporting more integrated approaches to management.
2. Classification of Pediatric Eating Disorders
2.1 Acute Severe Presentations
Severe Acute Malnutrition and Wasting
Severe acute malnutrition is formally defined by a weight-for-height or weight-for-length z-score falling below negative three standard deviations, a mid-upper arm circumference (MUAC) below 115 millimetres in children aged 6 to 59 months, or the presence of bilateral pitting edema. It represents the most immediately life-threatening end of the nutritional spectrum and demands urgent medical intervention regardless of the underlying etiology.
Failure to Thrive
Failure to thrive (FTT) describes a pattern of inadequate weight gain or physical growth in infancy and early childhood, conventionally defined as weight-for-age below the 3rd percentile or a downward crossing of two or more major percentile lines on a standardized growth chart. Unlike acute wasting, FTT emerges gradually and may reflect insufficient caloric intake, malabsorptive processes, elevated metabolic demands, psychosocial deprivation, or a combination of these factors. In clinical practice, it serves as an important sentinel indicator that should prompt systematic evaluation.
2.2 Chronic Nutritional Forms
Marasmus
Marasmus is characterized by severe and generalized wasting of both fat stores and skeletal muscle without associated edema, producing the characteristic ‘skin and bones’ appearance with visible rib and scapular prominences. It develops as a consequence of prolonged deficiency of both protein and total calories, typically in settings of chronic food insecurity or severe psychosocial neglect. Metabolic adaptations include a markedly reduced basal metabolic rate and growth arrest, with preservation of visceral protein synthesis until relatively late stages of disease progression.
Kwashiorkor
Kwashiorkor, sometimes described as edematous malnutrition, is characterized by bilateral pitting edema occurring in the context of relative protein deficiency. Clinically distinctive features include facial and pedal edema, ‘flaky paint’ skin desquamation, hepatomegaly secondary to fatty infiltration, and the flag sign—alternating bands of normally and abnormally pigmented hair reflecting alternating periods of nutritional stress and partial recovery. Kwashiorkor carries a higher mortality risk than marasmus, particularly when edema is extensive or complicated by infection.
2.3 Chronic Psychiatric Forms
Anorexia Nervosa
Anorexia nervosa (AN) is defined by persistent restriction of energy intake to a degree producing significantly low body weight for developmental stage, an intense and persistent fear of gaining weight or becoming fat, and a disturbance in the way one’s own body weight or shape is experienced. The DSM-5 revision removed the amenorrhea criterion and explicitly recognized developmentally appropriate presentations, acknowledging that children and younger adolescents may not articulate body image disturbance in the explicit terms that characterize adult presentations, yet demonstrate equivalent behavioral patterns.
Bulimia Nervosa
Bulimia nervosa (BN) involves recurrent episodes of binge eating—consumption of objectively large quantities of food within a discrete period, accompanied by a subjective sense of loss of control—followed by compensatory behaviors such as self-induced vomiting, misuse of laxatives or diuretics, fasting, or excessive exercise. Onset typically occurs around 13 to 14 years of age, frequently following a period of dietary restriction. Because body weight in bulimia nervosa is often within the normal range, the condition is frequently concealed and consequently underrecognized by clinicians and family members alike.
Avoidant/Restrictive Food Intake Disorder
Avoidant/restrictive food intake disorder (ARFID) describes a persistent pattern of limited food intake that is not motivated by concerns about body weight or shape, but rather by heightened sensory sensitivity to food properties, conditioned fear of aversive consequences such as choking or vomiting, or markedly low interest in eating. In terms of prevalence, ARFID is approximately as common as anorexia nervosa and bulimia nervosa combined, with a median age of onset around 11 years. Many affected children present initially to gastroenterology services before receiving an appropriate psychiatric evaluation.
Pica
Pica involves persistent ingestion of non-nutritive, non-food substances—including soil, paper, chalk, paint chips, or hair—sustained over a period of at least one month, in a manner that is developmentally and culturally inappropriate. It frequently co-occurs with autism spectrum disorder, intellectual disability, and deficiencies of iron or zinc. Clinical risks include heavy metal toxicity, gastrointestinal obstruction, and infectious complications.
3. Etiology
3.1 Biological Factors
Genetic factors contribute meaningfully to eating disorder susceptibility across all major diagnostic categories. Heritability estimates range from 40 to 60 percent for anorexia nervosa, with somewhat lower estimates for bulimia nervosa and binge eating disorder. Genome-wide association studies have identified susceptibility loci on chromosome 12 associated with AN, and striking overlap has been demonstrated between AN’s genetic architecture and that of obsessive-compulsive disorder on the one hand, and metabolic traits including low body mass index and high insulin sensitivity on the other—findings that have supported a reconceptualization of AN as a ‘metabo-psychiatric’ disorder rather than a purely psychological condition.
Hormonal dysregulation operates centrally in both nutritional and psychiatric eating disorders. In anorexia nervosa, suppression of the hypothalamic-pituitary-gonadal axis results in amenorrhea or delayed pubertal development, while declining leptin levels signal critically insufficient energy stores. Growth hormone resistance, with consequent reductions in insulin-like growth factor-1, impairs linear growth. Elevated cortisol drives catabolism. Comparable hormonal adaptations emerge in severe acute malnutrition, where they serve an initially protective function but become physiologically harmful with prolonged illness.
3.2 Psychological Factors
Anxiety is among the most consistently identified psychological risk factors across eating disorder categories. In ARFID, anxiety directly mediates food avoidance behaviors. In anorexia nervosa, dietary restriction frequently provides temporary anxiety relief, establishing a powerful negative reinforcement cycle that sustains illness. Perfectionism, harm avoidance, and cognitive rigidity—all traits associated with anxiety—are elevated in individuals with eating disorders as well as their biologically unaffected relatives, suggesting a shared heritable psychological substrate.
Depressive disorders frequently co-occur with eating pathology, particularly in bulimia nervosa, where shame and guilt following binge-purge episodes contribute to progressive mood deterioration. In children with severe malnutrition, depressive-spectrum symptoms may develop secondary to specific nutrient deficiencies—particularly thiamine, vitamin B12, and essential fatty acids—or may reflect the psychosocial consequences of poverty and chronic deprivation.
3.3 Social and Environmental Factors
Poverty and food insecurity represent the predominant causal drivers of both acute and chronic malnutrition at the population level. Household food insecurity—defined as limited or uncertain access to nutritionally adequate food—produces both quantitative dietary insufficiency and qualitative nutritional imbalance. The 2022 global estimate of 45 million children under five years experiencing wasting reflects persistent and profound socioeconomic inequity, concentrated most heavily in South Asia and sub-Saharan Africa.
Family dynamics exert significant influence on eating disorder risk at the individual level. Parental psychopathology and parental eating disorders increase offspring risk through genetic transmission, behavioral modeling, and disruptions to early feeding interactions. At the broader sociocultural level, pervasive exposure to idealized thin body images in digital and traditional media, peer commentary about physical appearance, and weight-based stigma fuel body dissatisfaction and disordered eating, particularly during adolescence when identity formation is most actively underway.
3.4 Medical Etiologies
A range of medical conditions must be systematically considered in the differential diagnosis of unexplained weight loss and impaired growth. Chronic infections—including HIV, tuberculosis, and intestinal parasitic infestations—reduce appetite, increase metabolic demands, and impair nutrient absorption. Gastrointestinal diseases such as inflammatory bowel disease, celiac disease, and eosinophilic esophagitis may closely mimic primary eating disorders in their clinical presentation. Malabsorptive conditions including cystic fibrosis and short bowel syndrome produce weight loss disproportionate to apparent dietary intake.
4. Pathogenesis
4.1 Metabolic Adaptations to Starvation
Regardless of underlying cause, negative energy balance initiates an organized cascade of metabolic adaptations. During the early phase, glycogenolysis and gluconeogenesis sustain glucose delivery to glucose-dependent tissues, particularly the brain. As fasting is prolonged, lipolysis mobilizes fatty acids for peripheral oxidation and ketogenesis provides an alternative cerebral fuel. A fundamental metabolic shift from anabolism to catabolism ensues: protein synthesis is downregulated, skeletal muscle is progressively degraded as a gluconeogenic substrate, and basal metabolic rate declines through reductions in thyroid hormone activity, sympathetic nervous system tone, and mitochondrial efficiency.
4.2 Hormonal Responses
Insulin suppression facilitates lipolysis and ketogenesis. Elevated cortisol maintains blood glucose availability but simultaneously contributes to immune suppression, progressive bone demineralization, and accelerated muscle catabolism. Growth hormone levels rise, but hepatic resistance to growth hormone signaling reduces insulin-like growth factor-1 and inhibits normal linear growth. Low T3 syndrome—a reduction in circulating triiodothyronine with preserved TSH—reflects adaptive metabolic downregulation and clinically manifests as bradycardia and hypothermia. Leptin levels fall proportionally with declining fat mass, theoretically driving increased hunger signals; however, in anorexia nervosa, these homeostatic signals are consistently overridden by psychological and neural mechanisms. Ghrelin is typically elevated, though patterns in AN are variable and not fully characterized.
4.3 Neurobiological Changes in Psychiatric Eating Disorders
Neuroimaging investigations in anorexia nervosa have documented altered striatal responses to food-related cues, with diminished anticipatory reward signaling that facilitates sustained dietary restriction. Serotonergic and dopaminergic systems demonstrate complex functional alterations, some of which appear to predate illness onset and may represent vulnerability factors rather than consequences of starvation alone. Functional MRI studies have revealed changes in corticolimbic circuits governing emotional processing, interoceptive awareness, and cognitive control. Some neurobiological changes show partial normalization following weight restoration, while persistent alterations in certain domains have been documented even after clinical recovery.
4.4 Immune and Multi-Organ Effects
Malnutrition produces profound immune dysfunction through lymphoid tissue atrophy, reduced lymphocyte counts and function, impaired phagocytic activity, and diminished complement activity. Cardiac muscle mass and contractile function decrease progressively, clinically manifesting as bradycardia and QTc interval prolongation—findings that substantially increase arrhythmia risk, particularly during the refeeding period when rapid electrolyte shifts occur. Hepatic steatosis in kwashiorkor reflects impaired lipoprotein export from a nutritionally depleted liver. Intestinal villous atrophy reduces mucosal enzyme activity and barrier integrity, perpetuating malabsorption and sustaining the vicious cycle of nutritional deterioration even when food becomes available.
5. Clinical Features
5.1 Acute Severe Presentations
Children presenting with severe acute malnutrition typically exhibit visible rib and scapular prominences, dramatic loss of subcutaneous fat, and generalized muscle wasting. In kwashiorkor, bilateral pitting edema beginning in the feet and lower limbs, hyperpigmentation, and skin desquamation are characteristic, and the flag sign may be evident in the hair. Clinical assessment of hydration status is complicated by profoundly altered body composition: conventional signs such as skin turgor are unreliable, and hypotension typically appears only in advanced stages. Hypoglycemia may be entirely asymptomatic or may present with altered consciousness or seizures. Electrolyte derangements—particularly hypokalemia, hypomagnesemia, and hypophosphatemia—carry immediate cardiac and neuromuscular risks. Infection in this population frequently presents atypically, with hypothermia rather than fever serving as the predominant sign of serious illness.
5.2 Chronic Nutritional Forms
Chronic malnutrition manifests clinically as linear growth stunting (height-for-age z-score below negative two standard deviations), developmental regression, sparse and easily pluckable hair, and dry or atrophic skin. Affected children characteristically display marked apathy and reduced spontaneous activity, with delays in the acquisition of motor and language developmental milestones. Hepatomegaly in kwashiorkor may produce a paradoxically full-appearing abdomen that superficially conceals underlying generalized wasting.
5.3 Chronic Psychiatric Forms
Anorexia nervosa in children frequently begins in a subtle and gradual fashion: progressive elimination of foods categorized as ‘unhealthy’ or ‘fattening,’ increasing rigidity around mealtimes, escalating caloric restriction, and heightened anxiety in food-related situations. The explicit fear of weight gain and clearly articulated body image disturbance that typify adult presentations may be absent or minimally expressed, replaced by food-specific fears, somatic complaints, or straightforward behavioral avoidance that does not involve weight-related cognitions. Binge-purge cycles in bulimia nervosa are typically conducted with considerable secrecy, and normal or near-normal body weight contributes substantially to delayed recognition.
ARFID presents as extreme food selectivity based primarily on sensory properties—texture, color, temperature, smell, or taste—or as marked avoidance of foods associated with a prior choking or vomiting episode. Physical signs common across psychiatric eating disorders include social withdrawal and progressive isolation, irritability, cold intolerance, lanugo hair, amenorrhea or delayed pubertal development, and bradycardia. These signs demand systematic assessment even when body weight falls within an apparently normal range.
6. Diagnosis
6.1 Anthropometric Assessment
Accurate and reproducible anthropometric measurement forms the cornerstone of nutritional diagnosis. A weight-for-height or weight-for-length z-score below negative three standard deviations identifies severe wasting; MUAC below 115 millimetres provides a portable, simple alternative well suited to community settings. Stunting is defined by a height-for-age z-score falling below negative two standard deviations. In older children and adolescents, age- and sex-specific BMI-for-age percentile charts account for normative variation in pubertal body composition; values below the 5th percentile indicate underweight and warrant further evaluation. Clinicians should remain alert to the possibility that patients with psychiatric eating disorders may attempt to artificially inflate measured body weight through water loading, wearing concealed objects, or other strategies.
6.2 Laboratory Evaluation
A complete blood count typically demonstrates normocytic normochromic anemia with superimposed microcytosis when iron deficiency is present. Leukopenia and lymphopenia reflect generalized immune suppression. Comprehensive metabolic panels should specifically assess serum potassium, magnesium, phosphate, and sodium; blood glucose monitoring is essential given the risk of asymptomatic hypoglycemia in malnourished children. Serum albumin below 25 g/L indicates severe protein deficiency, while prealbumin—with its shorter half-life of two to three days—provides a more dynamic and responsive index of nutritional status. Thyroid studies characteristically reveal low T3 with preserved TSH, representing a reversible adaptive response rather than primary hypothyroid disease.
6.3 Psychological and Behavioral Assessment
Psychological evaluation should employ validated instruments such as the Eating Disorder Examination and its developmentally adapted child version (ChEDE), which systematically assess dietary restriction patterns, binge-purge behaviors, and body image disturbance. DSM-5 criteria must be applied with developmental sensitivity and flexibility: children may lack the cognitive maturity or emotional vocabulary to explicitly articulate body image distortion, and behavioral markers consequently assume proportionally greater diagnostic weight. Family history of eating disorders, psychiatric illness, and psychosocial stressors should be systematically explored. Screening for comorbid depression, anxiety disorders, obsessive-compulsive disorder, and substance use is essential to guide integrated, comprehensive treatment planning.
6.4 Differential Diagnosis
| Presentation | Key Differentials | Distinguishing Features |
| Weight loss / poor growth | SAM, AN, IBD, celiac disease, hyperthyroidism | Growth chart trajectory, thyroid function, GI symptoms, eating attitudes |
| Food refusal / selectivity | ARFID, AN, autism spectrum, sensory processing disorder | Body image concerns absent in ARFID; autism features; sensory profile |
| Edema + poor growth | Kwashiorkor, nephrotic syndrome, heart failure, liver disease | Dietary history, albumin, renal and hepatic function |
| Binge eating + purging | Bulimia nervosa, BED, diabetes (insulin omission) | Compensatory behaviors, glycemic control, HbA1c |
| Ingestion of non-food items | Pica, OCD, intellectual disability, iron/zinc deficiency | Substance ingested, developmental assessment, micronutrient levels |
7. Management
7.1 Severe Acute Malnutrition: WHO Protocol
The World Health Organization’s phased management protocol for severe acute malnutrition has transformed outcomes in affected populations, reducing case fatality rates from the historical range of 30 to 50 percent to below 10 percent in settings where it is properly implemented. Children with complicated SAM—those presenting with medical complications or appetite failure—require inpatient stabilization, while those with uncomplicated SAM and preserved appetite can be managed effectively in community-based outpatient programs.
Stabilization Phase (Days 1–7)
The stabilization phase prioritizes correction of immediately life-threatening complications before cautious nutritional rehabilitation is initiated. Key clinical interventions include:
Hypoglycemia prevention requires feeding every two to three hours, including throughout the night. Documented hypoglycemia is treated with 50 mL of 10% glucose orally or by nasogastric tube, followed immediately by a therapeutic feed.
Hypothermia management requires maintaining ambient temperature between 25 and 30 degrees Celsius, using skin-to-skin contact where feasible, and providing warm blankets. Active external warming devices are avoided due to the risk of inducing cardiovascular collapse.
Rehydration in SAM uses ReSoMal rather than standard WHO oral rehydration solution. ReSoMal contains lower sodium (45 mmol/L) and higher potassium (40 mmol/L) concentrations specifically formulated for the altered physiology of severe malnutrition. Standard WHO-ORS is contraindicated in this context.
Empiric broad-spectrum antibiotic therapy is mandatory for all children with complicated SAM. Amoxicillin is the standard antibiotic for uncomplicated presentations; ampicillin combined with gentamicin is used for complicated inpatient cases.
Micronutrient supplementation includes vitamin A on Day 1 (with repeat dosing for ocular signs), along with zinc, folate, and copper throughout the management course. Iron supplementation is deliberately deferred to the rehabilitation phase to avoid potentiating infection risk during the vulnerable stabilization period.
Nutritional support begins with F-75 therapeutic milk formula (75 kcal/100 mL, 0.9 g protein/100 mL) at 130 mL/kg/day administered across 12 feeds, with mandatory overnight feeds to prevent hypoglycemia.
| Phase | Duration | Nutrition | Key Priority |
| Stabilization | Days 1–7 | F-75 at 130 mL/kg/day, 12 feeds | Treat complications; prevent hypoglycemia |
| Transition | Days 7–14 | Gradual shift to F-100 or RUTF | Restore appetite; monitor for refeeding syndrome |
| Rehabilitation | Weeks 2–6 | F-100 or RUTF at 150–220 kcal/kg/day | Target >10 g/kg/day weight gain; developmental stimulation |
| Follow-up | Months 1–6 | Family nutrition education; RUTF as needed | Prevent relapse; monitor growth |
Transition and Rehabilitation Phases
Return of appetite typically signals metabolic recovery and occurs two to seven days after the initiation of treatment. Transition to F-100 formula (100 kcal/100 mL, 2.9 g protein/100 mL) or ready-to-use therapeutic food (RUTF) proceeds gradually and is carefully monitored. During the full rehabilitation phase, the caloric target is 150 to 220 kcal/kg/day, with expected weight gain exceeding 10 g/kg/day indicating adequate progress. RUTF-based outpatient management programs have dramatically expanded treatment access for uncomplicated SAM at scale. Developmental stimulation through structured play, physical activity, and emotional engagement is an explicit and evidence-supported component of this phase.
7.2 Psychiatric Eating Disorders: Multidisciplinary Management
Team Composition
Effective management of psychiatric eating disorders in children and adolescents requires genuine coordination among a multidisciplinary clinical team. The pediatrician or adolescent medicine physician monitors medical stability, growth, cardiac function, and bone health. A child and adolescent psychiatrist provides diagnostic clarification and, where clinically indicated, pharmacotherapy. A registered dietitian guides nutritional rehabilitation and structured meal planning. A psychologist delivers evidence-based psychotherapy, while a social worker addresses family functioning, practical barriers to care, and school coordination.
Evidence-Based Psychotherapies
Family-Based Treatment (FBT) is the first-line psychotherapeutic intervention for adolescent anorexia nervosa, supported by multiple randomized controlled trials demonstrating superiority over individual therapeutic approaches. FBT proceeds through three sequential phases: in the first, parents assume complete control over the child’s food intake and eating environment to achieve medical stabilization and weight restoration; in the second, control over eating decisions is progressively returned to the adolescent; in the third, issues of developmental autonomy and identity are addressed. Full remission is achieved in 40 to 50 percent of patients by the conclusion of treatment, with continued clinical improvement documented during follow-up periods.
Enhanced Cognitive-Behavioral Therapy (CBT-E) has demonstrated particular effectiveness for bulimia nervosa and binge eating disorder, systematically targeting cognitive distortions concerning weight and shape, maladaptive behavioral cycles, and emotional dysregulation. Dialectical Behavior Therapy (DBT) is employed for presentations featuring marked emotional dysregulation, self-harm, or borderline personality features. Adolescent-Focused Therapy (AFT) provides an evidence-based individual treatment option when family involvement is clinically contraindicated or practically unavailable.
Nutritional Rehabilitation in Psychiatric Eating Disorders
Weight restoration in psychiatric eating disorders proceeds considerably more slowly than in SAM, both to minimize psychological resistance and to reduce the risk of refeeding syndrome. Caloric intake typically begins at 1,000 to 1,200 kcal/day and is advanced by 200 to 300 kcal every three to five days as tolerance is established. Target weight gain is 0.5 to 1.0 kg per week for hospitalized patients and 0.25 to 0.5 kg per week for outpatients. Structured, supervised meals with post-meal support are essential to prevent restriction and compensatory purging behaviors. Systematic, graduated exposure to feared ‘high-calorie’ foods challenges cognitive rigidity and enables the normalization of eating behavior over time.
Pharmacotherapy
No medications currently hold FDA approval for the treatment of anorexia nervosa in children, and pharmacotherapy plays a strictly secondary role focused on addressing comorbid psychiatric conditions. Fluoxetine is used for comorbid depression and anxiety, and at higher doses has demonstrated some efficacy in reducing binge-purge frequency in bulimia nervosa. Low-dose olanzapine (2.5 to 10 mg per day) may modestly accelerate weight gain and reduce obsessional preoccupation with food in anorexia nervosa, though the evidence base in pediatric populations remains limited, and regular metabolic monitoring is required given the risk of metabolic side effects.
Medical Monitoring and Refeeding Syndrome Prevention
Refeeding syndrome—characterized by hypophosphatemia, hypokalemia, hypomagnesemia, and potentially fatal cardiac and neurological complications arising from rapid metabolic shifts during nutritional rehabilitation—represents the most serious acute risk in this phase of treatment. Prevention requires slow and monitored caloric advancement, routine phosphate supplementation, prophylactic thiamine administration, and daily electrolyte monitoring for the first week of refeeding. Cardiac monitoring, including regular electrocardiographic assessment of QTc interval and resting heart rate, is essential for all patients undergoing nutritional rehabilitation, with continuous telemetry indicated during inpatient refeeding of high-risk patients.
8. Prevention and Public Health Strategies
8.1 Primary Prevention
Prevention efforts begin in the earliest years of life. Anticipatory guidance during routine well-child visits should address responsive feeding practices—recognizing and responding appropriately to infant hunger and satiety cues, avoiding coercive or overly restrictive parental feeding strategies, and providing age-appropriate diversity in food texture and flavor during the complementary feeding period. Families with identifiable risk factors, including parental eating disorder history or household food insecurity, warrant proactive, enhanced support from the earliest pediatric encounters.
8.2 Secondary Prevention
Routine growth monitoring at every pediatric health contact—with systematic plotting of measurements on standardized growth charts and clinical attention to downward percentile crossing rather than reliance on single data points—provides the most scalable and accessible early detection approach. The 2023 WHO guideline reinforces the integration of MUAC measurement into standard child health visits across all resource settings. School-based screening programs using validated brief instruments such as the SCOFF questionnaire can identify adolescents with disordered eating attitudes before full clinical syndromes develop. Expanded training of primary care providers, school nurses, and community health workers to recognize eating disorder presentations—including atypical forms in males, younger children, and minority populations—is essential to reduce diagnostic delays that currently average six to twelve months.
8.3 Tertiary Prevention and Systems-Level Action
For children already affected, structured family support programs and evidence-based caregiver psychoeducation reduce caregiver burden, improve treatment adherence, and support sustained recovery. Public health communication should consistently frame eating disorders as serious but treatable medical conditions, with the explicit aim of reducing stigma and encouraging early help-seeking behavior. Prevention messaging must carefully avoid inadvertently reinforcing restrictive eating: weight-inclusive, behavior-focused approaches emphasizing overall health and wellbeing rather than weight targets serve both eating disorder prevention and broader pediatric health promotion goals simultaneously.
Structural interventions addressing poverty, food insecurity, and inadequate healthcare access remain indispensable for tackling nutritional eating disorders at the population level. Community-based management programs for acute malnutrition, expanded school meal programs, and conditional cash transfer initiatives have demonstrated efficacy in reducing child wasting at scale. The integration of nutrition and mental health services—currently too frequently siloed within separate systems with minimal cross-referral—would enable appropriate identification and coordinated management regardless of where an affected child first presents for care.
9. Discussion
9.1 Toward a Unified Clinical Framework
A central argument of this review is that the nutritional and psychiatric frameworks for understanding pediatric eating disorders should be integrated rather than maintained as parallel, non-overlapping domains. Children recovering from severe acute malnutrition frequently develop food refusal, affective withdrawal, and disrupted attachment patterns that closely parallel features of ARFID. Children with anorexia nervosa develop medical complications—bradycardia, dangerous electrolyte derangements, progressive bone loss—that demand exactly the rigor of nutritional management applied to SAM. A unified clinical framework, while preserving meaningful categorical distinctions, allows clinicians to address each child’s actual clinical complexity rather than forcing a fit into pre-existing diagnostic silos.
The long-standing dichotomy between ‘organic’ and ‘functional’ eating disorders has become increasingly untenable in light of advances in neurobiological and genetic research. Genomic data linking anorexia nervosa to both psychiatric traits and metabolic characteristics, neuroimaging evidence of measurable brain structural changes in malnourished children, and the bidirectional relationship between malnutrition and psychological disturbance all argue for the consistent application of a biopsychosocial model across the full spectrum of pediatric eating presentations.
9.2 Persistent Gaps in Recognition and Access to Care
Despite substantial progress in establishing effective management protocols, the bottleneck in pediatric eating disorder care remains recognition. Evidence suggests that fewer than 20 percent of children with eating disorders access appropriate treatment, and diagnostic delays averaging six months to a year are common across clinical settings. Contributing factors include the atypical presentations characteristic of younger children, the fragmentation of care across gastroenterology, endocrinology, cardiology, and psychiatric services, and persistently inadequate coverage of eating disorder recognition in undergraduate and postgraduate medical training.
Access to evidence-based care remains profoundly inequitable globally. Community-based management programs for acute malnutrition currently reach only approximately 25 percent of affected children worldwide. Specialized pediatric eating disorder services for psychiatric conditions are heavily concentrated in urban centers of high-income countries, leaving rural, low-income, and ethnically minoritized populations without access to evidence-based care. Telehealth platforms, task-shifting to trained community health workers, and structural integration with existing maternal-child health systems offer the most promising scalable pathways to address this inequity.
9.3 Implications for Training and Health System Design
The convergence of nutritional and psychiatric eating disorders has direct and consequential implications for both clinical training and health system organization. Medical students and residents require meaningful exposure to the full spectrum of presentation, including practical training in growth monitoring, nutritional assessment, and the behavioral and psychological dimensions of feeding difficulties. Health systems need integrated shared care pathways that allow a child presenting to gastroenterology with food refusal, or to cardiology with unexplained bradycardia, to be efficiently screened for an underlying eating disorder and promptly connected with an appropriately composed multidisciplinary team.
10. Conclusion
Pediatric eating disorders—spanning acute severe malnutrition and chronic psychiatric conditions—represent a category of illness associated with enormous preventable suffering and mortality. The WHO protocol for severe acute malnutrition has already demonstrated what structured, evidence-based intervention can accomplish, reducing case fatality rates by more than half in settings where it is rigorously implemented. Family-Based Treatment and related evidence-based psychotherapies offer comparable hope for children and adolescents with anorexia nervosa and other psychiatric eating disorders.
What these successful approaches share is the centrality of early recognition: the child with SAM who receives timely intervention survives; the adolescent with anorexia nervosa who accesses evidence-based treatment within the first years of illness recovers at substantially higher rates than those identified and treated later. The principal challenge is therefore not scientific—an effective evidence base for intervention exists—but organizational and educational. Training clinicians to recognize the full spectrum of pediatric eating disorders, designing health systems capable of delivering genuinely integrated care, and systematically addressing the structural drivers of food insecurity and social vulnerability are the priorities that will determine outcomes for millions of affected children in the coming decades.
References
1. World Health Organization. Pocket book of hospital care for children: guidelines for the management of common childhood illnesses. 2nd ed. Geneva: WHO; 2013. Available from: https://www.who.int/publications/i/item/9789241548373
2. World Health Organization. Guideline on the prevention and management of wasting and nutritional oedema (acute malnutrition) in infants and children under 5 years. Geneva: WHO; 2023. Available from: https://www.who.int/publications/i/item/9789240068797
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5). Washington, DC: APA; 2013.
4. World Health Organization. ICD-11: International Classification of Diseases, 11th Revision. Geneva: WHO; 2019. Available from: https://icd.who.int/
5. UNICEF/WHO/World Bank Group. Levels and trends in child malnutrition: key findings of the 2023 edition of the joint child malnutrition estimates. Geneva: WHO; 2023. Available from: https://www.who.int/publications/i/item/9789240073791
6. Galmiche M, Déchelotte P, Lambert G, Tavolacci MP. Prevalence of eating disorders over the 2000–2018 period: a systematic literature review. Am J Clin Nutr. 2019;109(5):1402–1413. https://doi.org/10.1093/ajcn/nqy342
7. Nicholls DE, Lynn R, Viner RM. Childhood eating disorders: British national surveillance study. Br J Psychiatry. 2011;198(4):295–301. https://doi.org/10.1192/bjp.bp.110.081356
8. Lock J, Le Grange D. Treatment Manual for Anorexia Nervosa: A Family-Based Approach. 2nd ed. New York: Guilford Press; 2013.
9. Mehler PS, Andersen AE. Eating Disorders: A Guide to Medical Care and Complications. 3rd ed. Baltimore: Johns Hopkins University Press; 2017.
10. Eddy KT, Thomas JJ, Hastings E, et al. Prevalence of DSM-5 avoidant/restrictive food intake disorder in a pediatric gastroenterology healthcare network. Int J Eat Disord. 2015;48(5):464–470. https://doi.org/10.1002/eat.22350
11. Herpertz-Dahlmann B. Treatment of eating disorders in child and adolescent psychiatry. Curr Opin Psychiatry. 2017;30(6):438–445. https://doi.org/10.1097/YCO.0000000000000357
12. Golden NH, Katzman DK, Sawyer SM, et al. Update on the medical management of eating disorders in adolescents. J Adolesc Health. 2015;56(4):370–375. https://doi.org/10.1016/j.jadohealth.2014.11.020
13. Norris ML, Spettigue WJ, Katzman DK. Update on eating disorders: current perspectives on avoidant/restrictive food intake disorder in children and youth. Neuropsychiatr Dis Treat. 2016;12:213–218. https://doi.org/10.2147/NDT.S82538
14. Zipfel S, Giel KE, Bulik CM, Hay P, Schmidt U. Anorexia nervosa: aetiology, assessment, and treatment. Lancet Psychiatry. 2015;2(12):1099–1111. https://doi.org/10.1016/S2215-0366(15)00356-9
15. Garber AK, Mauldin K, Michihata N, Buckelew SM, Shafer MA, Moscicki AB. Higher calorie diets increase rate of weight gain and shorten hospital stay in hospitalized adolescents with anorexia nervosa. J Adolesc Health. 2013;53(5):579–584. https://doi.org/10.1016/j.jadohealth.2013.07.014